Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lyra Therapeutics, Inc. (LYRA) vs Seelos Therapeutics, Inc. (SEELQ)

Lyra Therapeutics, Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. Lyra Therapeutics, Inc. is the larger, with a market value of $870.0K against $700.0K — 1.2× the size. Seelos Therapeutics, Inc. grew revenue faster over the last twelve months: −51.5% against −74.1%. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs −7,266.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Seelos Therapeutics, Inc. leads on 9 and Lyra Therapeutics, Inc. on 4.

Valuation

Metric LYRA SEELQ Biotechnology median
P/E n/m n/m 7.88
P/S 0.78 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.51 n/m 0.74
EV/Sales (39.15) 0.50 10.73
Earnings yield (9,575.00%) 0.00% (28.84%)
Free cash flow yield (9,304.25%) 0.00% (23.03%)

Profitability

Metric LYRA SEELQ Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (7,794.47%) (1,480.04%) 0.00%
Net margin (7,266.08%) 203.13% 0.00%
Free cash flow margin (7,261.06%) (659.09%) 0.00%
Return on equity (6,594.98%) (10.86%) (57.72%)
Return on assets (56.45%) 57.34% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LYRA SEELQ Biotechnology median
Revenue growth (TTM) (74.05%) (51.45%) 5.64%
EPS growth (last fiscal year) 73.96% 62.72% —
Revenue growth, 5-year CAGR (20.38%) (22.63%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LYRA SEELQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.71 0.08 4.73
Net debt to EBITDA 0.52 0.09 0.96

Dividend

Metric LYRA SEELQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LYRA SEELQ Biotechnology median
Market cap 870.00k 700.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack